Saturday, 30 August 2008

Doctor-celebrity confidentiality: Does it even exist?

Mostly, it's a pretty good dole out to be rich and famous in America � unless you come down with a dread disease and mortal leaks your medical information. What do you do? What can you do?

As Christina Applegate ascertained last week, the options are limited.


She is just the latest fame to regain her medical troubles in a rag. Patrick Swayze, Britney Spears, Tom Cruise and Katie Holmes, Dennis Quaid, George Clooney, Farrah Fawcett � all in recent long time have seen information from their aesculapian records, or those of loved ones, spread in the iron out and on the Internet � without their license and sometimes in assault of the law.


Sometimes leaks stem from happenstance.


"I've been at the doctor's office and had some other person in the wait room call and report that I was in that respect � I think it's appalling," says actress Jennifer Garner.


But much celebrities surmise that medical personnel or loved ones have been lured by money to share versed details. In a celebrity-mad culture in which stars' medical problems have high news value and tabloids have deep pockets, the people's correct to know about Swayze's pancreatic malignant neoplastic disease or TomKat's baby sonogram or Clooney's injuries in a bike accident trumps celebrities' right to save their aesculapian records secret.


Unsurprisingly, celebrities, their publicists and their lawyers are bitter, regular though there's nothing new about this: Elizabeth Taylor's many medical crises take been rag fodder for decades. What's new now, they say, is the increased populace appetite for any celebrity news, the increased competition to catch that news and the cash some outlets wave to tempt people.


"Every time you think the bar can't get whatsoever lower, it gets depress. It's beyond outrageous," says publicist Ken Sunshine. "This is way, way over the line and indefensible in a civilized society."


Blair Berk, a Los Angeles lawyer world Health Organization has represented many celebrities, says no one should have to give up all rights to privateness just because he's notable.


"Somehow, none of the traditional boundaries of civic conduct appear to apply," Berk says. "It's not whining for someone wHO is noted to believe they lavatory see their physician in private and not sham it's passing to be published."


What to do? Celebrities can assert the leaker be prosecuted or sue the outlet that paying for and published the leak for invasion of privacy. Both would lease a long time, monetary value a caboodle of money, perpetuate the leak and even force more disclosures of records. They power not win, and the story of their medical condition will live incessantly on the Internet.


Or they could do what Applegate, 36, did, which was go public. One day after the tab National Enquirer reported the Emmy-nominated star of Samantha Who? had had a double mastectomy, Applegate was on Good Morning America gamely discussing the procedure.


Aside from showcasing Applegate's pluck, her appearance brought new attention to the option of contraceptive mastectomies for millions of women wHO have a history of breast malignant neoplastic disease.


But would she (or anybody) otherwise volunteer to discuss her medical condition on national television? Maybe. But after announcing on Aug. 9 that she had breast cancer and vowing then not to make whatever further statement, someone in a location to know about her treatment told the Enquirer, which routinely pays for information.


Applegate could have denied the level or ignored it. Or she could try to take control of it.


"She should be commended for the way she's handled this," says Los Angeles entertainment lawyer Martin Singer, world Health Organization represented Celine Dion in 2000 when she sued the Enquirer for $20 million for a story that she was pregnant with twins. (The story was retracted, and the rag apologized and donated money to charity.) "I can't say that everyone should do what (Applegate) did � it depends on each celeb. Sometimes the story is true only exaggerated. Sometimes you don't want to concede the story is true."


It's illegal under union law for a health care prole to divulge any person's records without authorization, says Chicago lawyer Deborah Gersh, who specializes in cases involving the 1996 Health Insurance Portability and Accountability Act.


Employees at UCLA Medical Center recently were caught snooping in piles of celebrities' records. Several, including doctors, were pink-slipped or disciplined this year, and one has been indicted on charges of selling information to the media.


But the law applies only to workers with access to medical records. "The National Enquirer (or any publication) is not a covered entity; it has no legal responsibility to protect that information, regular if they paid for it," says Gersh.


Enquirer editor in chief David Perel failed to return perennial calls, simply he did comment in the Aug. 22 edition of The New Republic on the John Edwards affair story and acknowledged that the paper pays for information � simply only if it's plant to be true. "We do it the way cops yield tipsters and informants," he said.


Journalism ethics good Kelly McBride, who teaches at the Poynter Institute journalism think tank, gives the Enquirer course credit for tenaciousness but low marks for ethics and credibility because paying for information taints it, she says.


"This is a follow-the-money question � there's more money in the celebrity market, so there's more money available to entice people to illegally release records," McBride says. "Medical information about a celebrity has very little populace value � it's by and large for titillation and amusement purposes."




More information

Wednesday, 20 August 2008

Jack Black Discusses the Inspiration for His Farting, Fat �Tropic Thunder� Character



"I have done lots of farting in movies. And I've been fat in almost all of my movies. So it's very close to home." �Jack Black [EW]

"The real triumph of this tour is that we haven't strangled each other. That's not to say it hasn't crossed my mind, or Stewart's, or Andy's." �Sting closes out the Police's final tour [Reuters via Yahoo]



"Karmically, we deserve the right guy. It's a tough thing, man. We make a pretty big noise." �Bassist Duff McKagan on Velvet Revolver's elusive quest for a front man with the right karmic fit [Billboard]



"It's a new-age, young, hip-hop [version of] Heat. These are young, cool, well-dressed, articulate bank robbers. [Chris Brown] be the little homey." �T.I. on The Heist � but we're not sure if Robert De Niro or Al Pacino was the "little homey" [MTV]



"Contractions have their own rhythm, right, so, we had to find our own rhythm to be a little bit above or on top of the contractions' rhythm. We had a good groove going."
Matthew McConaughey describes labor in perfect Matthew McConaughey language [CNN]







More info

Sunday, 10 August 2008

First U.S. Patient To Receive New Heart-Assist Device Doing Well After Surgery At University Of Michigan

�Anthony Shannon
made history on July 30. That's when he became the first person in the
United States to receive a new type of experimental and very high tech
heart-assist device. Called a DuraHeart, it was ingrained in his chest, and
connected to his flunk heart, to help pump his blood and keep him animated.



Shannon, a 62-year-old from Livonia, Mich., is doing well less than one
week after the operation, which was performed by a team led by surgeon
Francis Pagani, M.D., Ph.D. at the University of Michigan Cardiovascular
Center. Shannon is the erstwhile director of homeland security and emergency
management for Wayne County, Mich., and holds a Ph.D., in public
administration.



The DuraHeart, made by an Ann Arbor, Mich.-based company called Terumo
Heart Inc., uses advanced magnetic levitation technology. This "maglev"
approach, as it is called, means that a crucial, constantly revolving part
inside the ice hockey puck-sized ingrained device never touches the walls of
the pumping chamber.



Instead, it levitates in the middle, suspended in a magnetic field and
push blood on. The battery-powered device pushes blood from the center
to the body, pickings over nearly of the function of the left side of a
severely weakened heart.



As a result, DuraHeart may cause less impairment to blood cells and be less
likely to allow unsafe blood clots to shape, compared with other
heart-assisting devices that use mechanical pumps. It has already been put-upon
in 70 patients in Europe, where it received approval for commercial exercise in
2007 after a clinical tribulation.



Now, spirit failure patients at U-M and other centers across the U.S.
will feature the chance to volunteer for a clinical trial of the
DuraHeart, which is organism co-led by Pagani and by Yoshifumi Naka, M.D.,
Ph.D., from Columbia Presbyterian Hospital in New York. U-M is the national
training center for the trial, which is funded by Terumo Heart, and teams
from Columbia and the University of Louisville have already traveled to Ann
Arbor to acquire how to implant the device.



"The DuraHeart gives us a new, third-generation option for patients
with advanced heart failure wHO need serve to leave them to survive until
they john receive a heart transplant," says Pagani, who leads the U-M Center
for Circulatory Support.



He has led early national clinical trials of heart-assist devices,
including the HeartMate II, which in April received approval from the U.S.
Food and Drug Administration after a clinical run. U-M right away offers bosom
failure patients nearly a dozen different options to support their heart
social function, including heart transplants.



"This trial will test the DuraHeart's electric potential to overcome some of the
issues that take in been seen with other devices, including hemolysis caused
by fleece stress on red blood cells, and clotting jeopardy caused by blood that
does not circulate apace enough from all areas of the chamber," Pagani
explains. "It also clay to be seen if this device offers superior
durability, which might do it utilitarian as a destination therapy that could
remove the need for a heart transplant."



Shannon, whose heart has been weakening for nearly 20 years after a
ticker attack and clogged arteries damaged parting of his heart muscleman, is one
of 5.3 trillion Americans with heart failure.



Although not all spunk failure patients are candidates for a
heart-assist device or a heart transplant, tens of thousands could be. At
any given time, as many as 4,000 Americans are on the waiting heel for a
heart transpose, but only 2,C people receive new hearts in the U.S. each
year because of a shortage of suitable donor organs. Hundreds of multitude
each year die patch waiting for a heart.



In the past 20 years, many devices receive been developed to aid the
pith pump. Most have been left-ventricular attend devices or systems,
sometimes referred to as LVADs or LVASs. But others have aided the right
side of the middle or both sides - collectively, such devices are called
VADs.



The therapy has become common enough that hospitals can now apply for
accreditation as certified VAD centers, an indication of their feel
in implanting the devices and pickings care of patients before and after they
receive their device. This saltation, U-M became one of the first few such
accredited VAD centers in the land.



The DuraHeart was invented and highly-developed by a team light-emitting diode by Chisato
Nojiri, M.D., Ph.D., the chief executive officer of Terumo Heart. More than
a decade of research and development has lED to this clinical tryout and the
trial in Europe, as well as a trial in Japan that may begin afterwards this
year. Pagani serves as an unpaid adviser to Terumo Heart.



The clinical trial will inscribe 140 patients in a prospective,
non-randomized fashion, and up to 40 hospitals may eventually take portion.
All of the devices are existence made in Ann Arbor at Terumo Heart.



To implant a DuraHeart device, the sawbones diverts blood flow from the
seedy left ventricle of the heart into a titanium tube that leads into the
pumping chamber. The magnetically levitating impeller, a flat magnetic
disc, acts as a paddlewheel, turning constantly as it is magnetically
attracted to the turning motor within the pump caparison. This pushes blood
into a flexible artificial blood vessel, which is connected to the large
blood vessel called the ascent aorta.



By assisting the weak left ventricle, which is the heart sleeping room most
ordinarily affected by heart failure, the DuraHeart allows the heart muscle
to rest. It also provides better blood menstruation to the body, brainiac and organs
than a weak heart ever could - which helps patients prepare for the toilsome
surgery of a heart transplant.



Devices such as the HeartMate II and its predecessor HeartMate XVE, and
potentially the DuraHeart, may suit substitutes for heart transplants
over clip. They crataegus oxycantha allow patients to live for days with help from the
device, or to recover enough center function that they no longer need either
a device or a transplant. The HeartMate XVE is already sanctioned for this
type of "destination" use, and the HeartMate II is presently in a clinical
run for this purpose.



The DuraHeart may hold the same potential drop, says Pagani, but number one it
must be tested as a bridge to transplantation. With Anthony Shannon as the
pioneer, that test has now begun.


University of Michigan Health System
http://www.med.umich.edu


More info